A phase 3 trial evaluating benralizumab for the treatment of COPD did not meet its primary endpoint, according to AstraZeneca.

There is a clear unmet need for an ‘as needed’ therapy in PAH and PH-ILD, where patients lack an option for rapid symptom management. Supported by positive clinical data, RT234, an investigational ...

Researchers found smoking marijuana was associated with significantly increased risk of asthma, including among people who have never used tobacco cigarettes, and may also be associated with chronic ...

Up to 235% increase in real-world adherence compared to published norms (20–40%), across ~850 chronic obstructive pulmonary disease (COPD) and asthma patients. >60% patients achieved an average ...

Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disease characterized by progressive surfactant accumulation and hypoxemia caused by autoantibodies against granulocyte–macrophage ...

CILA’s proprietary, gene-agnostic platform, CIL-Key™, is designed to enable the development of breakthrough inhaled RNA therapeutics and vaccines for pulmonary diseases — potentially unlocking new ...

The European Medicines Agency (EMA) has recommended a change in composition for Trixeo Aerosphere, also known as Riltrava Aerosphere. Both drugs are used for maintenance treatment in a subset of ...

Switching from a metered-dose to a dry-powder inhaler after a formulary change increased emergency department visits and hospitalizations in people with COPD or asthma. The absolute changes in risk ...

MERCY MEDICAL CENTER. 57 YEAR OLD STEPHANIE HARRIS HAS BOTH ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE, OR COPD. I STARTED SMOKING AROUND THE AGE OF 14 OR. 15. AND I COMPLETELY STOPPED MAYBE ...

• We are confident that quality of life is improved with triple therapy (inhaled corticosteroids (ICS) plus long-acting beta2-agonists (LABA) plus long-acting muscarinic antagonists (LAMA)) compared ...

TUESDAY, July 1, 2025 (HealthDay News) -- Digital inhalers may help predict the occurrence of acute exacerbations of chronic obstructive pulmonary disease (COPD) for patients in an ambulatory setting, ...